PATENT CLAIM ANALYSIS

Application Number: 15746597
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "210180"]

Abstract:
The invention relates generally to compounds that modulate the activity of TGFβR-1 and TGFβ R-2, pharmaceutical compositions containing said compounds and methods of treating proliferative disorders and disorders of dysregulated apoptosis, such as cancer, utilizing the compounds of the invention.

Claim (Index 13):
The use of a compound according to  claim 1  or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment of diseases or conditions for which a TGF\u03b2R antagonist is indicated.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 86.0
- Lexical Diversity: 1.41935
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15747843', '14977709', '13266921', '12085880', '15027585']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7877239595556773
- 35 USC 102 Novelty (BERT): 0.5537002154862254
- Combined Prediction Score: 0.7643215851487322
- Mean Citation Score: 368.039356
- Max Citation Score: 403.93115
- Similarity Product: 327.56124125150444

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test